MedPath

Comparison of the difference in the number of oocytes obtained by administering the ovarian stimulation treatment as usually with administering it only once and later.

Phase 1
Conditions
Oocyte donation
Therapeutic area: Body processes [G] - Reproductive physiologi cal processes [G08]
Registration Number
EUCTR2019-001343-44-ES
Lead Sponsor
Instituto Bernabeu
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Recruiting
Sex
Female
Target Recruitment
180
Inclusion Criteria

1. To be considered fit to enter the Bernabeu Institute oocyte donation program (Annex I)
2. Age between 18 and 32 years
3. BMI> 18 and <30
4. Antral follicle count> 12 (adding both ovaries)
5. Presence of both ovaries
6. Ability to participate and comply with the study protocol
7. Having given written consent
8. Not having received treatment with ovulation stimulators in the 3 months prior to the start of the stimulation.
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range 180
F.1.3 Elderly (>=65 years) no
F.1.3.1 Number of subjects for this age range

Exclusion Criteria

1. Diagnosis of endometriosis at any stage
2. AFC> 20
3. SOP
4. Concurrent participation in another study

Study & Design

Study Type
Interventional clinical trial of medicinal product
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath